Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.490
+0.050 (3.47%)
At close: Oct 6, 2025, 4:00 PM EDT
1.490
0.00 (0.00%)
After-hours: Oct 6, 2025, 7:36 PM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $80.82 million as of October 6, 2025. Its market cap has decreased by -0.73% in one year.
Market Cap
80.82M
Enterprise Value
296.26M
1-Year Change
-0.73%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $299.25M to $80.82M, a decrease of -72.99%. That is a compound annual growth rate of -14.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 75.66M | 2.87% |
| Dec 31, 2024 | 73.55M | -80.23% |
| Dec 29, 2023 | 372.10M | 5,065.15% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.02M | -47.56% |
| Dec 31, 2020 | 156.41M | -32.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |